Cargando…
Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification
Extrahepatic cholangiocarcinoma (ECC) is an uncommon and devastating malignancy that mainly consists of adenocarcinoma. Adenosquamous carcinoma is a rare histologic type and accounts for 2–5% of ECC. It reports that 3.6–8.5% of ECC patients carry Her-2 amplification. A 45-year-old woman was admitted...
Autores principales: | Hong, Ye, Li, Xiaofen, Cao, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983672/ https://www.ncbi.nlm.nih.gov/pubmed/33763343 http://dx.doi.org/10.3389/fonc.2021.538328 |
Ejemplares similares
-
Adenosquamous Carcinoma of the Extrahepatic Bile Duct
por: Gupta, Deepika, et al.
Publicado: (2022) -
Adenosquamous Carcinoma of Extrahepatic Bile Duct: A Case Report
por: Lim, Sin Hyung, et al.
Publicado: (2007) -
Concomitant adenosquamous carcinoma and cystadenocarcinoma of the extrahepatic bile duct: A case report
por: Lu, Bing-Jie, et al.
Publicado: (2019) -
Case report: Long-term clinical benefit of pyrotinib therapy following trastuzumab resistance in HER2-amplification recurrent mucinous ovarian carcinoma
por: Fang, Xiangming, et al.
Publicado: (2022) -
Adenosquamous Carcinoma of the Breast: Case Report and Literature Review
por: Priyadarshini, Shista, et al.
Publicado: (2022)